📰 Scientific Session News
Page 11 - Scientific Session News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Scientific Session. Real-time updates on events, politics, business and more.
February 15, 2022
No Effect of Omecamtiv Mecarbil On Exercise Capacity in Patients with Heart Failure with Reduced Ejection Fraction Results Will Be Presented in Late Breaking Clinical Trial Session at the American... | February 15, 2022
February 11, 2022
Bridgeline Digital Inc (NASDAQ:BLIN) saw its revenue rise by 51% year-over-year in 1Q 2022 off the strength of its subscription and licenses revenue. The...
February 10, 2022
/PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF) a mental healthcare company advancing innovative treatments and...
February 10, 2022
/PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF) a mental healthcare company advancing innovative treatments and...
February 10, 2022
Bridgeline Digital Inc (NASDAQ:BLIN) saw its revenue rise by 51% year-over-year in 1Q 2022 off the strength of its subscription and licenses revenue. The...
January 4, 2022
FAIRFAX, VA (PRWEB) January 04, 2022 -- Dennis Calnon, MD, MASNC, nuclear cardiologist and director of cardiac imaging at the OhioHealth Riverside Methodist
December 15, 2021
- Spin-out from University of Oxford built on a decade of world-leading research on blood cancers and breakthrough innovation in single-cell multi-omic...
December 15, 2021
- Spin-out from University of Oxford built on a decade of world-leading research on blood cancers and breakthrough innovation in single-cell multi-omic analysis by founders Professor Adam Mead
December 15, 2021
- Spin-out from University of Oxford built on a decade of world-leading research on blood cancers and breakthrough innovation in single-cell multi-omic...
November 22, 2021
/PRNewswire/ -- Latest news from institutes affiliated with Kawasaki INnovation Gateway at SKYFRONT (KING SKYFRONT) with Braizon Therapeutics announcing...